483 Fresenius Kabi USA Jun 2018

483 Fresenius Kabi USA Jun 2018

William Leonard FDA, Sony Mathews FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi USA - Grand Island, NY, United States facility and issued inspectional observations (via FDA 483) on 29 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jun 2018
  • Location: Grand Island, United States
  • FEI: 3001833549
Add To Cart